119 HR 1922 IH: Ensuring Access to Essential Drugs Act U.S. House of Representatives 2025-03-06 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I119th CONGRESS1st SessionH. R. 1922IN THE HOUSE OF REPRESENTATIVESMarch 6, 2025Mr. Garbarino (for himself, Mrs. Harshbarger, and Mr. Suozzi) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concernedA BILLTo amend title XVIII of the Social Security Act to exempt certain drugs from the part D manufacturer discount program under the Medicare program.

1.

Short title

This Act may be cited as the Ensuring Access to Essential Drugs Act.

2.

Exempting certain drugs from the part D manufacturer discount program under the Medicare program

Section 1860D–14C(g)(2) of the Social Security Act (42 U.S.C. 1395w–114c(g)(2)) is amended—(1)in subparagraph (A), by striking and at the end;(2)in subparagraph (B), by striking the period and inserting ; and; and(3)by adding at the end the following new subparagraph:(C)does not include an orally administered drug—(i)for which a new drug application was approved under section 505 of the Federal Food, Drug, and Cosmetic Act; and(ii)that has been granted a narrow exception permitting reclassification as a noninnovator multiple source drug under the Medicaid drug rebate program by the Centers for Medicare & Medicaid Services..